3-Methoxy-4-ethoxyphenethylamine
| Clinical data | |
|---|---|
| Other names | MEPEA |
| Routes of administration | Oral[1] |
| ATC code |
|
| Pharmacokinetic data | |
| Duration of action | Unknown[1] |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider |
|
| UNII | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.199.597 |
| Chemical and physical data | |
| Formula | C11H17NO2 |
| Molar mass | 195.262 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| NY (what is this?) (verify) | |
3-Methoxy-4-ethoxyphenethylamine (MEPEA) is a lesser-known drug.[1] It was first synthesized by Alexander Shulgin.[1] In his book PiHKAL (Phenethylamines i Have Known And Loved), the minimum dosage is listed as 300 mg, and the duration unknown.[1] MEPEA is said to produce a light lifting feeling and a +1 on the Shulgin Rating Scale.[1] Very little data exists about the pharmacological properties, metabolism, and toxicity of MEPEA.[1]
See also
References
This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.